Prognosis of weight reduction by thyroid function

Prognosis of weight reduction by thyroid function - THYDIET

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016718

Enrollment

300

Registered

2015-04-20

Start date

2015-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Obesity outpatients (BMI over 25)undergoing weight reduction. 2.Age: 20 years of age and older. 3.Men and women

Exclusion criteria

Exclusion criteria: 1.Autoimmune thyroid disease patients undergoing treatment. 2.Patients under thyroid hormone (Levothyroxine) supplementation. 3.Patients being administered medicine which affects thyroid function, such as interferon. 4.Patients whom the chief physician determines are not applicable for the study.

Design outcomes

Primary

Measure	Time frame
serum TSH, free T4, free T3, body weight (before and after six-month weight reduction regime), body fat composition (visceral fat)	—

Secondary

Measure	Time frame
BMI,blood pressure,CAVI,total blood cell count,TP,Alb,T-Bil,D-Bil,AST,ALT,Gamma-GTP, BUN, Cr, Na, K, Cl, Ca, P, HbA1c, BS, IRI, T-Chol, HDL-C, LDL-C, TG, hsCRP, adiponectin, leptin	—

Countries

Japan

Contacts

Public ContactNoriko Satoh-Asahara

National Hospital Organization, Kyoto Medical Center Clinical Research Institute

nsato@kyotolan.hosp.go.jp075-641-9161

Outcome results